GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » T&R Biofab Co Ltd (XKRX:246710) » Definitions » Capex-to-Operating-Income

T&R Biofab Co (XKRX:246710) Capex-to-Operating-Income : 0.00 (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is T&R Biofab Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

T&R Biofab Co's Capital Expenditure for the three months ended in Jun. 2024 was ₩-1,107.79 Mil. Its Operating Income for the three months ended in Jun. 2024 was ₩-4,189.16 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


T&R Biofab Co Capex-to-Operating-Income Historical Data

The historical data trend for T&R Biofab Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T&R Biofab Co Capex-to-Operating-Income Chart

T&R Biofab Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

T&R Biofab Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of T&R Biofab Co's Capex-to-Operating-Income

For the Medical Devices subindustry, T&R Biofab Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T&R Biofab Co's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, T&R Biofab Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where T&R Biofab Co's Capex-to-Operating-Income falls into.



T&R Biofab Co Capex-to-Operating-Income Calculation

T&R Biofab Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-12729.881) / -12652.702
=N/A

T&R Biofab Co's Capex-to-Operating-Income for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-1107.789) / -4189.163
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


T&R Biofab Co  (XKRX:246710) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


T&R Biofab Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of T&R Biofab Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


T&R Biofab Co Business Description

Traded in Other Exchanges
N/A
Address
Sangidaehak-ro 237, Gyeonggi-do, Siheung-si, KOR, 540
T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.

T&R Biofab Co Headlines

No Headlines